Form 4: Marvell Technology Executive Sells 6,000 Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Marvell Technology's EVP, Chief Operations Officer, Chris Koopmans, sold 6,000 shares of common stock at $89.14 per share under a pre-arranged 10b5-1 trading plan.

Summary

  • Chris Koopmans, EVP and Chief Operations Officer at Marvell Technology, sold 6,000 shares of common stock.
  • The sale occurred on November 15, 2024, at a price of $89.14 per share.
  • The transaction was executed under a pre-arranged 10b5-1 trading plan established on June 17, 2024.
  • Following the sale, Koopmans directly owns 0 shares and indirectly owns 103,244 shares through the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an executive stock sale under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

Executive stock sales are a common occurrence and are often pre-planned to avoid accusations of insider trading. This sale by a Marvell executive is not unusual and is likely part of a personal financial strategy.

Comparison to Industry Standards

  • Executive stock sales are a regular occurrence in publicly traded companies, and the use of 10b5-1 plans is a common practice to ensure compliance with insider trading regulations.
  • Comparable companies such as Broadcom, Qualcomm, and Nvidia also see similar filings from their executives.

Stakeholder Impact

  • The sale is unlikely to have a significant impact on shareholders as it is a routine transaction under a pre-arranged plan.

Key Dates

DateDescription
06/17/2024Date of the 10b5-1 trading plan.
11/15/2024Date of the stock sale transaction.
11/18/2024Date the form was signed.

Keywords

Marvell Technology, MRVL, insider trading, stock sale, 10b5-1 plan, Chris Koopmans, executive sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.